FINWIRES · TerminalLIVE
FINWIRES

Nomura Adjusts Sichuan Kelun-Biotech Biopharmaceutical's Price Target to HK$544.42 From HK$438.30, Keeps at Buy

By

Sichuan Kelun-Biotech Biopharmaceutical Co (HKG:6990) has an average rating of buy and mean price target of HK$550.70, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Asia

Nomura Adjusts Info Edge (India)'s Price Target to INR1,320 From INR1,500, Keeps at Buy

Info Edge (India) (NSE:NAUKRI, BOM: 532777) has an average rating of overweight and mean price target of 1,358.11 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BOM:532777$NSE:NAUKRI
Asia

Jefferies Adjusts Prestige Estates Projects' Price Target to INR1,675 From INR1,635, Keeps at Buy

Prestige Estates Projects (NSE:PRESTIGE, BOM:533274) has an average rating of buy and mean price target of 1,780.44 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BOM:533274$NSE:PRESTIGE
Asia

Jefferies Adjusts Torrent Pharmaceuticals' Price Target to INR5,350 From INR4,690, Keeps at Buy

Torrent Pharmaceuticals (NSE:TORNTPHARM, BOM:500420) has an average rating of overweight and mean price target of 4,663.57 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BOM:500420$NSE:TORNTPHARM